Synaptogenix Inc (SNPX)

[runncoach]

Good presentation. Not sure how many were watching or familiar with the company as most on these boards are. They do expect to receive the Nasdaq listing soon. They expect the current trial to complete in Q3 of next year. Presumably (my opinion) we could see results well before the end of 2022. FragileX and MS are ready to go to trial but didn't give a time frame. PD, TBI, stroke, etc are still running additional pre-clinical studies. There was a comparison with 2 additional AD companies, market caps, MOAs, results, etc that certainly painted us in an undervalued light. Company is big on PKCe as the most critical biomarker relating to the synapses. Peer review of the last trial is currently being worked on for publication. My take is not any time in the too immediate future. Synthetic news was great for company as they prepare for future trials. Current trial should minimize daily fluctuations that are created by having a too severe population and too short of a trial to minimize placebo effect. They also have the expectation that scores will also increase due to a second round of the drug.

On a side note compassionate use patient #3 from the presentation is Frank Carney one of the brothers to co-found Pizza Hut. The history channel has been running a series on "Foods that made America" and I caught the episode on development of Pizza as a fast food industry this week. It was kind of neat watching the portrayal of Frank and his brother take the industry from no one even knowing what pizza was outside of NYC to the multi billion dollar industry today. Take about pioneers.